Arcturus Therapeutics Holdings Inc (ARCT)
EBITDA Growth
-175.60%
Quarterly · Period ending:
ARCT EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-175.60%period ending
Latest reported-175.60%period ending
ARCT Quarterly EBITDA YoY % (-179.63% → -175.60%)
Year-over-year change
High-resolution chart · PNG
ARCT ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -175.5984% | |
| -98.162% | |
| 31.0072% | |
| -104.3331% | |
| 48.9761% | |
| 48.0329% | |
| -174.7036% | |
| 57.133% | |
| 67.88% | |
| -148.9574% | |
| -108.8563% | |
| 57.5109% | |
| -149.9317% | |
| 203.8844% | |
| 418.7223% | |
| 35.7923% | |
| 61.7423% | |
| 12.434% | |
| -22.1725% | |
| -157.7519% | |
| -443.6688% | |
| -514.0563% | |
| -135.8619% | |
| -187.4791% | |
| -17,391.2281% | |
| -43.509% | |
| -3,125.679% | |
| -70.6934% | |
| 100.5742% | |
| -0.7585% | |
| -820.4545% | |
| -78.2166% | |
| -927.1081% | |
| -92.2047% | |
| 99.2546% | |
| 70.2276% | |
| 83.6186% | |
| 35.576% | |
| -18.9641% | |
| -83.6545% | |
| -14.2968% | |
| 0.0192% | |
| 24.6927% | |
| 59.2796% | |
| 34.0151% | |
| 33.3504% | |
| -16.8262% | |
| -237.3844% | |
| -555.1926% | |
| -2,401.278% | |
| -2,192.6829% | |
| -1,096.5649% | |
| -179.6253% |